Profiling the Tumor-Infiltrating Lymphocytes in Gastric Cancer Reveals Its Implication in the Prognosis

Profiling the Tumor-Infiltrating Lymphocytes in Gastric Cancer Reveals Its Implication in the Prognosis

Gastric cancer is the fifth most common malignancy and the third leading cause of cancer-related mortality worldwide. Immunotherapy offers promising new treatment options for gastric cancer patients; however, it is only effective in a limited fraction of patients. In this study, we evaluated the com...

Full description

Bibliographic Details
Main Authors:	Weiqiang Yu, Shuaili Wang, Qiqi Rong, Olugbenga Emmanuel Ajayi, Kongwang Hu, Qingfa Wu
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Genes
Subjects:	gastric cancer immunotherapy tumor-infiltrating lymphocytes hub-genes prognosis
Online Access:	https://www.mdpi.com/2073-4425/13/6/1017

Similar Items

Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01)

T‐cells infiltration mediates the association between neutrophil/lymphocyte ratio and survival in gastric cancer
by: Qifei He, et al.
Published: (2023-08-01)

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
by: Elliott J. Yee, et al.
Published: (2024-04-01)

The relationship of the tertiary lymphoid structures with the tumor-infiltrating lymphocytes and its prognostic value in gastric cancer
by: Nana Zhang, et al.
Published: (2021-08-01)

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
by: Soon Auck Hong, et al.
Published: (2020-08-01)

CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer
by: Shanping Shi, et al.
Published: (2020-05-01)

Immune Cell Infiltrate and Prognosis in Gastric Cancer
by: Niko Kemi, et al.
Published: (2020-12-01)

DISC1 as a prognostic biomarker correlated with immune infiltrates in gastric cancer
by: Shiyao Zheng, et al.
Published: (2023-04-01)

Helios Expression in Tumor-Infiltrating Lymphocytes Correlates with Overall Survival of Advanced Gastric Cancer Patients
by: Wei-Ming Chen, et al.
Published: (2020-09-01)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
by: Gorenšek R, et al.
Published: (2023-11-01)

Investigating the Potential of Isolating and Expanding Tumour-Infiltrating Lymphocytes from Adult Sarcoma
by: Alice Ko, et al.
Published: (2022-01-01)

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
by: Dong Liu, et al.
Published: (2022-04-01)

Analysis of the Clinicopathological Characteristics, Prognosis, and Lymphocyte Infiltration of Esophageal Neuroendocrine Neoplasms: A Surgery-Based Cohort and Propensity-Score Matching Study
by: Long Zhang, et al.
Published: (2023-03-01)

Deep Learning Predicts EBV Status in Gastric Cancer Based on Spatial Patterns of Lymphocyte Infiltration
by: Baoyi Zhang, et al.
Published: (2021-11-01)

Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer
by: Canxuan Li, et al.
Published: (2023-03-01)

Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer
by: Chao Li, et al.
Published: (2023-06-01)

Immune infiltration difference between tumour and adjacent normal regions is prognostic for gastric cancer patients
by: Baoyi Zhang, et al.
Published: (2022-03-01)

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01)

Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8<sup>+</sup> T Cells in Non-Melanoma Cancers Compared to Melanoma
by: Aishwarya Gokuldass, et al.
Published: (2020-11-01)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
by: Nobuya Daitoku, et al.
Published: (2022-09-01)

The Significance of Fibrinogen in Combination with the Neutrophil to Lymphocyte Ratio in Predicting the Prognosis of Patients with Gastric Cancer
by: Li X, et al.
Published: (2022-08-01)

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer
by: Rui Chen, et al.
Published: (2022-09-01)

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
by: Elise Ballot, et al.
Published: (2020-08-01)

CD81 and CD82 expressing tumor-infiltrating lymphocytes in the NSCLC tumor microenvironment play a crucial role in T-cell activation and cytokine production
by: Kwangmin Na, et al.
Published: (2024-03-01)

LYMPHOCYTE SUBPOPULATIONS IN GASTRIC AND COLORECTAL CANCER PATIENTS AFTER IMMUNOTHERAPY WITH ACTIVATED LYMPHOCYTES
by: E. V. Abakushina, et al.
Published: (2014-11-01)

Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection
by: Qingnuo Zeng, et al.
Published: (2024-03-01)

Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis
by: Yiting Geng, et al.
Published: (2015-10-01)

Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma
by: Zhuo Li, et al.
Published: (2023-09-01)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
by: Fu-xue Huang, et al.
Published: (2022-08-01)

Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA
by: Zexi He, et al.
Published: (2022-09-01)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
by: Nicholas J. Bevins, et al.
Published: (2022-11-01)

Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes
by: Chaoqun Li, et al.
Published: (2023-12-01)

Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis
by: Xinyi Lei, et al.
Published: (2021-06-01)

Evaluation of CD4+ tumor-infiltrating lymphocyte association with some clinicopathological indices of oral squamous cell carcinoma
by: Farnaz Mohajertehran, et al.
Published: (2022-01-01)

High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma
by: Qiqi Zhu, et al.
Published: (2023-09-01)

Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
by: Hao Yang, et al.
Published: (2023-03-01)

CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
by: Weiyan Hou, et al.
Published: (2022-10-01)

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
by: Melani Luque, et al.
Published: (2022-12-01)

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
by: Miao Qin, et al.
Published: (2022-06-01)

Three Cases of Lymphocytic Infiltration of the Eyelid
by: Kyoko Sugioka, et al.
Published: (2021-05-01)